HPC Biosciences (Delisted) financials and balance sheet

BSE: 535217Agricultural Food & other Products

Last traded ₹25.68 on 29 Jul 2024

Delisted on 15 Dec 2025.

9 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.HPC Biosciences annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹4.77 Cr, year to Mar 2013

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue2.3
  2. Depreciation−0.5
  3. Other income+0.1
  4. Profit before tax1.2
  5. Tax0.0
  6. Net profit1.2

Profit and loss

Standalone, ₹ crore, years to March.HPC Biosciences half-yearly results

₹ croreMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 7 AugMar 2021
Revenue from operations4.773.533.262.012.441.951.601.202.29
––––––0.40––
Materials and goods bought––0.40–––0.040.08–
Employee costs––––––0.10––
Other expenses––––––0.26––
Operating profit before depreciation––––––1.20––
Operating margin––––––75.2%––
Materials, % of revenue––––––2.4%––
Employee costs, % of revenue––––––6.1%––
Other expenses, % of revenue––––––16.2%––
Depreciation and amortisation1.331.361.411.380.990.840.72–0.51
Operating profit after depreciation––––––0.49––
Other income–––––0.140.090.100.09
Finance costs––––––0.000.00–
One-off items––––––0.00––
Profit before tax2.981.260.760.500.570.230.580.361.19
0.000.020.050.040.060.040.020.020.02
Net profit2.981.240.710.460.510.200.550.341.17
Net margin62.4%35.1%21.6%22.9%20.8%10.1%34.6%28.1%51.2%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018 and Mar 2021: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2020: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2021, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Filed 14 JunMar 2020Filed 7 AugMar 2021Sep 2021Half yearFiled 22 Jan
31.331.7–32.9
Share capital16.016.0–16.0
Reserves15.415.7–17.0
Borrowings0.00.0–0.0
0.60.5–0.3
Liabilities due after a year0.00.0–0.0
Total assets31.932.1–33.2
8.27.6–6.8
23.724.6–26.4
Net debt−0.3−0.3–−0.6
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018 and Mar 2021, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2021, after the latest full year: the cash flow over its six months.

₹ croreSep 2021Half year
0.28
0.33
Of which working capital0.01
Capital spending0.00
Free cash flow0.28
Cash from investing−0.07
Cash from financing0.05
Dividends paid0.00
Shares issued0.00
Net change in cash0.25
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 7 AugMar 2021
Earnings per share₹0.03₹0.01–₹0.00–
Diluted earnings per share₹0.03₹0.01–₹0.00–
Earnings per share is left blank for the year to Mar 2019: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give.

Ratios

Standalone, years to March.

RatioMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 7 AugMar 2021
Revenue growth−26.1%−7.4%−38.4%21.6%−20.4%−17.7%−25.0%90.6%
Net profit growth−58.5%−43.0%−34.6%10.2%−61.2%181.3%−39.3%247.6%
Earnings per share growth––––−62.5%–––
–––––1.8%1.1%–
––––––−0.7 pts–
From the net margin––––––−0.3 pts–
From asset turnover––––––−0.4 pts–
From borrowing––––––0.0 pts–
Return on capital employed–––––1.6%––
Debt to equity–––––0.000.00–
Receivable days–––––1,2081,650–
Inventory days–––––8,2103,767–
Payable days–––––0––
Cash conversion cycle, days–––––9,417––
Working capital days–––––5,2237,246–
Asset turnover–––––0.050.04–
Assets per rupee of net worth–––––1.021.02–
Sales per rupee of plant–––––0.380.33–
No balance sheet is on record for the years to Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017, Mar 2018 and Mar 2021, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Measure10 years5 years3 years
Revenue growth, yearly rate–2.6%5.5%
Profit growth, yearly rate–20.5%81.1%
Return on equity, average––1.4%
Net margin, average31.9%29.0%38.0%
Asset turnover, average––0.04
Debt to equity, average––0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Receivables growth less revenue growthOur threshold 0 percentage points–––––––27.47–
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––––––−107.55–
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––––––1,486.77–
Effective tax ratePublished threshold 17.16 per cent0.071.596.878.7310.2715.093.986.211.85
A threshold marked as ours has no published figure; it is the line we read the check against.